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LETTERS TO THE EDITOR
The major issue raised by these questions is whether antiphos-
pholipid antibodies are related to valve disease in patients with lupus
erythematosus or antiphospholipid syndrome
. Khamashta et al
. (3),
studied 132 patients with lupus by transthoracic echocardiography
and found valve disease in 30 (23%), valve vegetations in 9 and
mitral regurgitation by continuous wave Doppler study in 21
. Fifty
patients (38%) had either anticardiolipin antibodies (84%) or lupus
anticoagulant (16%)
. Of those with anticardiolipin antibodies, 38%
to 50% had low levels of either IgG or IgM immunogtobulin antibodies
.
Furthermore, 33% of patients with valve vegetations and 52% of those
with mitral regurgitation had absent or low levels of antibodies
. Thus,
it could be argued that their data did not establish a causal relation
between anticandiolipin antibodies and valve disease
.
Calve et al, (4) studied 25 patients with lupus by transthoracic
echocardiography and found valve disease in 9 (36%)
. Eight (89%) of
these nine had anticardiolipin antibodies, 59
t 44 IU for ISO and
13 t 14 IU for ISMM
. Seven (44%) of 16 patients with normal valves
had 40 or ISM anticardiolipin antibodies (48
t
51 IU and 7 t 5 IU
.
respectively), When both groups were compared, no difference was
found in the frequency and concentration of antibodies (p = 0
.55) .
The level of antibody positivity in relation w valve disease was not
given
. The investigators conclude that an association between
antiphospholipid antibodies and systemic lupus erythematosus
valve disease may exist but does not necessarily indicate a causal
relation.
Nihoyannopoulos et al . (5) found cardiac disease by trans-
thoracic echocardiography in 50 (54%) of 94 patients with lupus
. Of
these 50 patients, 39 (78%) had IgG or ISM anticardiolipin antibod-
ies, however, only 7 (18%) of them had very high levels (>100 U)
and 43 (82%) had a wide range of positivity (9 to 100 U) . The
majority (72%) of patir 's with cardiac disease were in this last
group, but no mention is made of the low positivity level and
cardiac abnormalities . Furthermore, 26% of patients without
antibodies had cardiac abnormalities and 23% with high levels
had a normal heart . The investigators concluded that this associa-
tion may suggest a causal relation, but their results do not establish
this linnk.
Calve et al . (6). in 28 patients with primary antiphospholipid
syndrome found valve disease by transthoracic echocardiography in
10 (36%). No difference was found in the concentration of IgG
anticandidipin antibody between patients with abnormal or normal
valves (91 t 132 IU and 60 ± 54 IU, respectively ; p > 0.2).
They
concluded that their study did not elucidate a causal relation
between antiphospholipid antibodies and valve disease in the pri-
mary antiphosphoipid syndrome .
Finally
. Li et al . (7) studied 50 patients with lupus by trans-
thoracic echocardiography and found valve regurgitation in up to
68% of them. Thirty patients (64%) had ISO or ISM anticardiolipin
antibodies
. However, no association was found between the pres-
ent
: or severity of valve lesions and the presence of antibodies (p >
0.2). Similarly, in our study, which used transesophageal echocar
. ,
diography, there was no difference in the frequency of valve disease
between the patients with lupus who had (77%) or did not have
(72%) antiphospholipid antibodies
.
Thus, we believe that the pathogenesis of systemic lupus erythe-
matosus valve disease is still unknown and our results and those of
others do not support the hypothesis that wttiphosphoipid antibod-
ies are a primary pathogenetic or risk factor
.
CARLOS A. ROLDAN, MD
MICHAEL CRAWFORD, MD, FACC
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assessing Collateral Development After
Acute Myocardial Infarction
Fujita et al . (1) using quantitative coronary angiography demon-
strated in seven patients an increase in collateral circulation to an
occluded infarct-related artery on serial angiograpby between day I
and 6 weeks later. Their novel approach to assessment of collateral
circulation was based on the mealsureav nt of the proximal diameter
of the recipient vessel and demonstration of an increase in that
measurement from day I to 6 weeks while there was no change in
the measurements of the donor vessel .
The results and conclusions of this study rest on the measure-
ment of the recipient vessel diameter and, more precisely, on the
amount of contrast material within the lumen . Several important
technical and methodologic aspects were not reported: 1) Was the
assessment of paired angiograms blinded? 2) What was the power
and rate of contrast material injection into the donor vessel because
this clearly would determine the amount of contrast material appear-
ing in the recipient vessel? 3) How long was the cineangiogram taken
for in filming the filling of the recipient vessel and how long after the
injection of the donor vessel was the measurement of the diameter of
the recipient vessel performed because these would also affect the
amount of contrast material within the lumen? 4) Was the first
injection of the donor vessel used for analysis? If not, an accumu-
lation of contrast material in background tissues could have added
error to the subsequent measurements . 5) We are told that the
recipient vessel was measured at the proximal point; however, that
point was not precisely the same between day I and 6 weeks . A
more proximal measurement could be responsible for difference in
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diameter rather than a greater distention of the artery because of the
collateral flow . 6) The validation of the quantitative technique was
performed with phantoms 2 to 3 .5 mm hi sire, whereas the mea-
surement of interest,-that is, the diameter of the recipient vessel-
was significantly smaller. 7) Although appropriate care was taken to
ensure an end-diastolic measurement, the authors report a signifi-
cant decrease in the heart rate between the two studies, suggesting
that the diastolic filling time was significantly longer at the time of
the second measurement and, therefore, a greater filling of the
recipient vessel could have occurred .
The results of this small, elegant study are critically dependent
on the control of technical factors, some of which I have mentioned .
Without this knowledge, the results of this study need to be
interpreted with caution and require further validation .
DR. ANATOLY LANGER
St. Michael's Hospital
30 Bond Street, Suite 701A
Toronto, Ontario MSB I W8, Canada
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Reply
The main aim of our study was not to validate the method of
quantitative angiography combined with the cardiac image analysis
system (Cardio 500, Kontron Instruments) (I) but to evaluate
whether there exists additional collateral growth after the acute
myocardial infarction. The further development of collateral vessels
after the acute infarction was substantiated not only by the mea-
surement of coronary lumen diameters, but also by the improvement
in regional myocardial wall motion in the infarct areas (2) .
We consider Langer's criticisms regarding technical and meth-
odologic aspects of our study to be important . An observer of
coronary cineangiograms was unaware of the sequence of paired
angiograms of each patient in our study . Because coronary angiog-
raphy was performed with hand injections of contrast medium, the
amount of contrast medium appearing in the recipient artery may
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have been dependent on the power and rate of injection . For this
reason, the use of a power injector appears to be more desirable
.
However, in our study, we measured donor and recipient arteries
simultaneously in the same end-diastolic frame
. Because each artery
served as its own control, the difference in the power and rate of
injection may have been minimized . We selected the end-diastolic
frame where the amount of contrast medium in the recipient artery
was assumed to be largest . There was no accumulation of contrast
medium in myocardial tissues after each contrast injection. Special
care was taken to make paired measurements at the same site by
using anatomic references such as side branches . Okumura et al. (3)
have validated the accuracy and precision of the same angiographic
image analysis system with the use of phantom models of coronary
arteries with diameters of 0 .5, 0 .8 and 1 mm . Finally, although the
diastolic filling time may be crucial, the diastolic aortic pressure
appears to be more important as a determinant of the diameter of
donor and recipient arteries, which was quite comparable between
the two stages of infarction . We expect that Langer will improve this
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